These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10989839)

  • 1. In vivo studies on nasal preparations of ciprofloxacin hydrochloride.
    Ozsoy Y; Tunçel T; Can A; Akev N; Birteksöz S; Gerçeker A
    Pharmazie; 2000 Aug; 55(8):607-9. PubMed ID: 10989839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular poloxamer-based ciprofloxacin hydrochloride in situ forming gels.
    Mansour M; Mansour S; Mortada ND; Abd Elhady SS
    Drug Dev Ind Pharm; 2008 Jul; 34(7):744-52. PubMed ID: 18612913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo evaluation of nicotine lyophilised nasal insert in sheep.
    McInnes FJ; Thapa P; Baillie AJ; Welling PG; Watson DG; Gibson I; Nolan A; Stevens HN
    Int J Pharm; 2005 Nov; 304(1-2):72-82. PubMed ID: 16183221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged delivery of ciprofloxacin hydrochloride from hydrophilic ocular inserts.
    Samanta A; Ghosal SK
    Acta Pol Pharm; 2004; 61(5):343-9. PubMed ID: 15747690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcorneal iontophoresis for delivery of ciprofloxacin hydrochloride.
    Vaka SR; Sammeta SM; Day LB; Murthy SN
    Curr Eye Res; 2008 Aug; 33(8):661-7. PubMed ID: 18696341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ophthalmic controlled release in situ gelling systems for ciprofloxacin based on polymeric carriers.
    Al-Kassas RS; El-Khatib MM
    Drug Deliv; 2009 Apr; 16(3):145-52. PubMed ID: 19514974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diffusion of latex nanospheres and the effective (microscopic) viscosity of HPMC gels.
    Ruenraroengsak P; Florence AT
    Int J Pharm; 2005 Jul; 298(2):361-6. PubMed ID: 15939561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular bioavailability of ciprofloxacin in sustained release formulations.
    Ke TL; Cagle G; Schlech B; Lorenzetti OJ; Mattern J
    J Ocul Pharmacol Ther; 2001 Dec; 17(6):555-63. PubMed ID: 11777179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative bioavailability of two oral formulations of ciprofloxacin.
    Trejo D; Toledo A; Carrasco-Portugal Mdel C; Aguilar-Cota ME; Herrera JE; Flores-Murrieta FJ
    Proc West Pharmacol Soc; 2003; 46():134-5. PubMed ID: 14699910
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of enrofloxacin in Korean catfish (Silurus asotus).
    Kim MS; Lim JH; Park BK; Hwang YH; Yun HI
    J Vet Pharmacol Ther; 2006 Oct; 29(5):397-402. PubMed ID: 16958784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of ciprofloxacin after single intravenous and repeat oral administration to cats.
    Albarellos GA; Kreil VE; Landoni MF
    J Vet Pharmacol Ther; 2004 Jun; 27(3):155-62. PubMed ID: 15189301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human bioavailability of propranolol from a matrix-in-cylinder system with a HPMC-Gelucire core.
    Mehuys E; Remon JP; Korst A; Van Bortel L; Mols R; Augustijns P; Porter C; Vervaet C
    J Control Release; 2005 Oct; 107(3):523-36. PubMed ID: 16055224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal administration of metoclopramide from different dosage forms: in vitro, ex vivo, and in vivo evaluation.
    Tas C; Ozkan CK; Savaser A; Ozkan Y; Tasdemir U; Altunay H
    Drug Deliv; 2009 Apr; 16(3):167-75. PubMed ID: 19514977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative bioavailability of sulfamethoxazole in co-trimoxazole suspensions containing different thickness agents.
    Marchetti JM; Shuhama IK; Bentley MV; Lara EH
    Boll Chim Farm; 1999 Oct; 138(9):461-4. PubMed ID: 10682404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Is the switch of fluoroquinolones from intravenous to oral administration useful in an intensive care unit? Economical approach].
    Turc J; Eve O; Tran Van D; Wey PF; Martinez JY
    Ann Fr Anesth Reanim; 2009 Feb; 28(2):179-80. PubMed ID: 19171451
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro/in vivo studies on a buccal bioadhesive tablet formulation of carbamazepine.
    Ikinci G; Capan Y; Senel S; Alaaddinoğlu E; Dalkara T; Hincal AA
    Pharmazie; 2000 Oct; 55(10):762-5. PubMed ID: 11082839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and residues of ciprofloxacin and its metabolites in broiler chickens.
    Anadón A; Martínez-Larrañaga MR; Iturbe J; Martínez MA; Díaz MJ; Frejo MT; Martínez M
    Res Vet Sci; 2001 Oct; 71(2):101-9. PubMed ID: 11883887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Floating matrix dosage form for phenoporlamine hydrochloride based on gas forming agent: in vitro and in vivo evaluation in healthy volunteers.
    Xu X; Sun M; Zhi F; Hu Y
    Int J Pharm; 2006 Mar; 310(1-2):139-45. PubMed ID: 16413710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymer based solutions of bupranolol hydrochloride for intranasal systemic delivery.
    Mishra B; Sankar C; Mishra M
    J Drug Target; 2011 Apr; 19(3):204-11. PubMed ID: 20550434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.